دورية أكاديمية
Prevalence, prescriptions, outcomes and costs of type 2 diabetes patients with or without prior coronary artery disease or stroke: a longitudinal 5-year claims-data analysis of over 7 million inhabitants
| العنوان: | Prevalence, prescriptions, outcomes and costs of type 2 diabetes patients with or without prior coronary artery disease or stroke: a longitudinal 5-year claims-data analysis of over 7 million inhabitants |
|---|---|
| المؤلفون: | Aldo Pietro Maggioni, Letizia Dondi, Felicita Andreotti, Giulia Ronconi, Silvia Calabria, Carlo Piccinni, Antonella Pedrini, Imma Esposito, Nello Martini |
| المصدر: | Therapeutic Advances in Chronic Disease, Vol 12 (2021) |
| بيانات النشر: | SAGE Publishing, 2021. |
| سنة النشر: | 2021 |
| المجموعة: | LCC:Therapeutics. Pharmacology |
| مصطلحات موضوعية: | Therapeutics. Pharmacology, RM1-950 |
| الوصف: | Aims: To analyze the prevalence, comorbidities, outcomes and costs of type 2 diabetes mellitus (T2DM) patients with and without coronary artery disease (CAD) or stroke in a population of over 7 million inhabitants. Methods: T2DM patients were identified in 2015 (accrual period) from the Ricerca e Salute (ReS) database linking administrative records to demographics. Based on 2013–2015 information, four cohorts were considered: #1 with CAD and/or stroke; #2 without CAD and/or stroke; #3 with chronic CAD but no myocardial infarction or stroke; #4 with chronic CAD undergoing percutaneous coronary interventions (PCI). Hospitalizations, drugs and other outpatient care were assessed from 2015 to 2017. Results: The prevalence of T2DM was 6% (441,085/7,365,954). CAD and/or stroke in the previous 3 years affected 7.5% of T2DM patients (33,153); this cohort was generally older, of male sex, with more comorbidities, prescriptions, and hospital admissions (50.5% versus 13.4% during the first follow-up year) compared to cohort #2. Yearly costs were over three-fold for cohort #1 versus #2, main drivers being hospitalizations in the former and drugs in the latter. Two-year cardiovascular events were recorded significantly more commonly in cohort #4 compared to the other cohorts. Guideline-recommended lipid-lowering therapy was |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2040-6231 20406223 |
| Relation: | https://doaj.org/toc/2040-6231 |
| DOI: | 10.1177/20406223211026390 |
| URL الوصول: | https://doaj.org/article/1e624c5b0e6d44eaafd3c88757479359 |
| رقم الأكسشن: | edsdoj.1e624c5b0e6d44eaafd3c88757479359 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 20406231 20406223 |
|---|---|
| DOI: | 10.1177/20406223211026390 |